Farmaci sintomatici specifici e aspecifici per il trattamento acuto dell'attacco emicranico: Nuove opzioni terapeutiche

Translated title of the contribution: Specific and non-specific drugs in the treatment of migraine attacks: New options

G. Nappi, G. Sances, C. Tassorelli, R. Ambrosio, G. Sandrini

Research output: Contribution to journalArticle

Abstract

The effectiveness of various symptomatic drugs has been documented by controlled clinical trials. A review of the data from the literature has identified a group of substances that proved significantly better than placebo in at least two controlled trials. These drugs include triptans, ergots, non-steroidal anti-inflammatory drugs and anti-emetics. With the exception of ergotamine, which is ineffective or may even worsen nausea, all of them possess both analgesic and anti-emetic effects, provided that they are used according to the proper dosage and administration route. The choice of the appropriate drug, formulation and route of administration is a crucial step in the therapeutic approach of migraine. This choice must be guided by the clinical characteristics of the migraine attack, co-morbid or associated conditions, drug-related factors and patient' preferences.

Translated title of the contributionSpecific and non-specific drugs in the treatment of migraine attacks: New options
Original languageItalian
Pages (from-to)69-83
Number of pages15
JournalConfinia Cephalalgica
Volume9
Issue number2
Publication statusPublished - 2000

ASJC Scopus subject areas

  • Clinical Neurology

Fingerprint Dive into the research topics of 'Specific and non-specific drugs in the treatment of migraine attacks: New options'. Together they form a unique fingerprint.

Cite this